CTI BioPharma Corp. (CTIC)
Jun 26, 2023 - CTIC was delisted (reason: acquired by Sobi)
9.09
0.00 (0.00%)
Inactive · Last trade price
on Jun 23, 2023
CTI BioPharma Employees
CTI BioPharma had 128 employees as of December 31, 2022. The number of employees increased by 4 or 3.23% compared to the previous year.
Employees
128
Change (1Y)
4
Growth (1Y)
3.23%
Revenue / Employee
$596,606
Profits / Employee
-$545,189
Market Cap
1.20B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 128 | 4 | 3.23% |
Dec 31, 2021 | 124 | 101 | 439.13% |
Dec 31, 2020 | 23 | -2 | -8.00% |
Dec 31, 2019 | 25 | -21 | -45.65% |
Dec 31, 2018 | 46 | -11 | -19.30% |
Dec 31, 2017 | 57 | -43 | -43.00% |
Dec 31, 2016 | 100 | -49 | -32.89% |
Dec 31, 2015 | 149 | 24 | 19.20% |
Dec 31, 2014 | 125 | 19 | 17.92% |
Dec 31, 2013 | 106 | -10 | -8.62% |
Dec 31, 2012 | 116 | 21 | 22.11% |
Dec 31, 2011 | 95 | 8 | 9.20% |
Dec 31, 2010 | 87 | -17 | -16.35% |
Dec 31, 2009 | 104 | -90 | -46.39% |
Dec 31, 2008 | 194 | -36 | -15.65% |
Dec 31, 2007 | 230 | 33 | 16.75% |
Dec 31, 2006 | 197 | -17 | -7.94% |
Dec 31, 2005 | 214 | -188 | -46.77% |
Dec 31, 2004 | 402 | 30 | 8.06% |
Dec 31, 2003 | 372 | 86 | 30.07% |
Dec 31, 2002 | 286 | 48 | 20.17% |
Dec 31, 2001 | 238 | 91 | 61.90% |
Dec 31, 2000 | 147 | 50 | 51.55% |
Dec 31, 1999 | 97 | -68 | -41.21% |
Dec 31, 1998 | 165 | -14 | -7.82% |
Dec 31, 1997 | 179 | 61 | 51.69% |
Dec 31, 1996 | 118 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
CTIC News
- 1 year ago - Sobi completes acquisition of CTI BioPharma Corp. - PRNewsWire
- 1 year ago - Sobi successfully completes tender offer for all outstanding shares of common stock of CTI BioPharma Corp. - PRNewsWire
- 1 year ago - CTI BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CTI BioPharma Corp. - CTIC - Business Wire
- 1 year ago - CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders - PRNewsWire
- 1 year ago - Sobi commences tender offer for all outstanding shares of common stock of CTI BioPharma Corp. - PRNewsWire
- 1 year ago - Swedish drugmaker SOBI to acquire Seattle biotech giant CTI BioPharma for $1.7B - GeekWire
- 1 year ago - CTI BioPharma Soars After Agreeing $1.7 Billion Sale. Biotech Deals Keep Coming. - Barrons
- 1 year ago - CTI BioPharma soars on deal news, while Upstart and Rivian climb after earnings - Market Watch